Othus, M. et al. (2023) Early mortality risk with non-intensive acute myeloid leukemia (AML) therapies: analysis of 1336 patients from MRC/NCRI and SWOG. Leukemia and Lymphoma, 64(1), pp. 250-252. (doi: 10.1080/10428194.2022.2131416) (PMID:36226777)
Full text not currently available from Enlighten.
Abstract
No abstract available.
Item Type: | Articles (Letter) |
---|---|
Status: | Published |
Refereed: | Yes |
Glasgow Author(s) Enlighten ID: | Burnett, Professor Alan |
Authors: | Othus, M., Thomas, I., Wang, X., Ariti, C., Mehta, P., Sydenham, M., Hills, R. K., Burnett, A. K., Nand, S., Assouline, S., Michaelis, L. C., Erba, H. P., Russell, N., Kerr, K. F., Walter, R. B., and Dennis, M. |
College/School: | College of Medical Veterinary and Life Sciences > School of Cancer Sciences |
Journal Name: | Leukemia and Lymphoma |
Publisher: | Taylor & Francis |
ISSN: | 1042-8194 |
ISSN (Online): | 1029-2403 |
Published Online: | 13 October 2022 |
University Staff: Request a correction | Enlighten Editors: Update this record